Tyler, Texas
United States
20
2025-10-02
The entities that hold a legal rights for patent applications filed by inventor IDELL Steven:
Steven IDELL from Tyler, US has applied for patents for these inventions. The list has both pending applications and granted patents:
INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#2 | 2024-02-22Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#3 | 2023-03-30INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#4 | 2022-03-31Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#5 | 2021-10-28POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#6 | 2021-07-15Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitors
#7 | 2020-05-28Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#8 | 2020-05-28POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#9 | 2019-08-22Compositions and methods for administration of an enzyme to a subject's airway
#10 | 2018-05-24COMPOSITIONS AND METHODS FOR ADMINISTRATION OF AN ENZYME TO A SUBJECT'S AIRWAY
#11 | 2018-03-29INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#12 | 2018-02-22POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#13 | 2017-09-07Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#14 | 2016-10-06Fibrinolytic potential: a test of pleural fluid to predict outcomes and guide dosing in fibrinolytic therapy
#15 | 2016-09-29COMPOSITIONS AND METHODS FOR ADMINISTRATION OF AN ENZYME TO A SUBJECT'S AIRWAY
#16 | 2016-09-22Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#17 | 2015-12-24Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
#18 | 2009-09-10Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosis
#19 | 2008-02-19Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
#20 | 2005-03-03Regulation of urokinase receptor expression by phosphoglycerate kinase
1655413 ⎘